For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) closed the day trading at $0.45 down -13.85% from the previous closing price of $0.52. In other words, the price has decreased by -$13.85 from its previous closing price. On the day, 2.64 million shares were traded.
Ratios:
For a better understanding of CERO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 0.73.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when YK Bioventures Opportunities G sold 2,998,908 shares for $0.06 per share. The transaction valued at 179,934 led to the insider holds 13,005,169 shares of the business.
YK Bioventures Opportunities G sold 1,614,541 shares of CERO for $113,018 on Dec 12 ’24. The 10% Owner now owns 16,004,077 shares after completing the transaction at $0.07 per share. On Dec 11 ’24, another insider, YK Bioventures Opportunities G, who serves as the 10% Owner of the company, sold 1,343,801 shares for $0.08 each. As a result, the insider received 107,504 and left with 17,618,618 shares of the company.
Stock Price History:
Over the past 52 weeks, CERO has reached a high of $104.00, while it has fallen to a 52-week low of $0.47. The 50-Day Moving Average of the stock is -37.86%, while the 200-Day Moving Average is calculated to be -93.08%.
Shares Statistics:
A total of 7.72M shares are outstanding, with a floating share count of 5.44M. Insiders hold about 29.58% of the company’s shares, while institutions hold 9.08% stake in the company.
